Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Research Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
J Int AIDS Soc. 2019 Mar;22 Suppl 1(Suppl Suppl 1):e25234. doi: 10.1002/jia2.25234.
INTRODUCTION: Scale-up of HIV self-testing (HIVST) will play a key role in meeting the United Nation's 90-90-90 targets. Delayed re-reading of used HIVST devices has been used by early implementation studies to validate the performance of self-test kits and to estimate HIV positivity among self-testers. We investigated the stability of results on used devices under controlled conditions to assess its potential as a quality assurance approach for HIVST scale-up. METHODS: 444 OraQuick HIV-1/2 rapid antibody tests were conducted using commercial plasma from two HIV-positive donors and HIV-negative plasma (high-reactive n = 148, weak-reactive n = 148 and non-reactive n = 148) and incubated them for six months under four conditions (combinations of high and low temperatures and humidity). Devices were re-read daily for one week, weekly for one subsequent month and then once a month by independent readers unaware of the previous results. We used multistage transition models to investigate rates of change in device results, and between storage conditions. RESULTS AND DISCUSSION: There was a high incidence of device instability. Forty-three (29%) of 148 initially non-reactive results became false weak-reactive results. These changes were observed across all incubation conditions, the earliest on Day 4 (n = 9 kits). No initially HIV-reactive results changed to a non-reactive result. There were no significant associations between storage conditions and hazard of results transition. We observed substantial statistical agreement between independent re-readers over time (agreement range: 0.74 to 0.96). CONCLUSIONS: Delayed re-reading of used OraQuick HIV-1/2 rapid antibody tests is not currently a valid methodological approach to quality assurance and monitoring as we observed a high incidence (29%) of true non-reactive tests changing to false weak-reactive and therefore its use may overestimate true HIV positivity.
简介:扩大艾滋病毒自检(HIVST)将在实现联合国 90-90-90 目标方面发挥关键作用。早期实施研究中使用了延迟重读用过的 HIVST 设备,以验证自检试剂盒的性能并估计自检者中的艾滋病毒阳性率。我们在受控条件下研究了用过的设备结果的稳定性,以评估其作为 HIVST 扩大规模的质量保证方法的潜力。 方法:使用来自两个艾滋病毒阳性供体的商业血浆和艾滋病毒阴性血浆(高反应性 n=148、弱反应性 n=148 和非反应性 n=148)对 444 个 OraQuick HIV-1/2 快速抗体检测进行检测,并将其在四种条件(高温和低温与高湿度和低湿度的组合)下孵育六个月。设备每天重新读取一次,持续一周,然后每月一次,由不知道先前结果的独立读者进行。我们使用多阶段过渡模型来研究设备结果变化的速率,以及在不同储存条件下的变化。 结果与讨论:设备不稳定的发生率很高。最初非反应性的 43 个结果(占 148 个的 29%)变成了假弱阳性结果。这些变化在所有孵育条件下都观察到,最早在第 4 天(n=9 个试剂盒)。最初 HIV 反应性结果没有变为非反应性结果。储存条件与结果转换的危险之间没有显著关联。我们观察到独立重读读者随时间的变化具有很大的统计学一致性(一致性范围:0.74 至 0.96)。 结论:延迟重读用过的 OraQuick HIV-1/2 快速抗体检测目前不是一种有效的质量保证和监测方法,因为我们观察到高发生率(29%)的真正非反应性检测结果变为假弱阳性,因此其使用可能会高估真实的艾滋病毒阳性率。
AIDS Res Ther. 2019-9-12
Front Public Health. 2025-1-14
J Am Med Inform Assoc. 2025-2-1
J Acquir Immune Defic Syndr. 2025-1-1
J Immunoassay Immunochem. 2022-3-4
AIDS Res Ther. 2019-9-12
J Acquir Immune Defic Syndr. 2017-8-1